Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0001209191-22-033920

Director acquired 298 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Grant Grady III Director 2022-06-01 Option exercise +298 1,012 D
Derivatives
Grant Grady III Director 2022-06-01 Option exercise · Restricted Stock Unit −298 595 D
Loading xslF345X03/doc4.xml…